Skip to content
go to content
HOME > What we do > HIRA's Role and Function > Rule Making

Rule Making

  • Korea Pharmaceutical Information Service (KPIS)
  • Korea Pharmaceutical Information Service procedure
  • 1. Drug Informatization Management (Standardization of drug codes)
  •  ·  Drug manufacturers and importers apply for standardized code of KPIS after obtaining MFDS approval. KPIS notifies
  •     the applicant the code within 30 days of receiving application (Standardization , full declaration, and ATC code
  •     linkage of all drugs distributed in Korea)
  • 2. Manage and disclose information on drug production, import, supply, and consumption
  •  ·  Collects and manages distribution information of drug suppliers. Information about unsafe drugs which are
  •     suspended from sales by KFDA are sent to KPIS real-time. Then the information is provided to drug suppliers
  •     (manufacturer, importer, and wholesaler)
  •  ·  Produce national statistics of drug distribution information for the government, public, and institutions using DW of
  •     collected information through portal system

  • Operational Performance
  •  ·  Ensure transparency of drug distribution by managing national standardized drug code
  •  ·  Foster healthy development of drug industry by providing drug distribution information
  •  ·  Save health insurance expenditure by analyzing drug distribution and usage information (2013: 22.8 billion KRW)
  •  ·  Protect public health by managing pharmaceutical distribution information real-time. Using the state of the art ICT
  •     technologies such as Internet of Things (loT)
  •    * Harmful drug use will be prevented by linking the information to RFID Tag.
  •  ·  Generate national statistics based on drug distribution information (production, profit, and etc)